What is the primary FDA label indication for Olmesartan?

Olmesartan is primarily indicated for the treatment of hypertension, which is a condition characterized by elevated blood pressure. It belongs to a class of medications known as angiotensin II receptor blockers (ARBs) and works by relaxing blood vessels, allowing blood to flow more easily and thereby lowering blood pressure.

The FDA labeling emphasizes hypertension as the primary condition for which olmesartan is prescribed due to its effectiveness in managing this disorder and helping to reduce the risk of cardiovascular events related to prolonged high blood pressure. Olmesartan is not indicated for heart failure, diabetes management, or angina treatment; those conditions require different therapeutic approaches and medications. By focusing on high blood pressure control, olmesartan plays a crucial role in the overall management of cardiovascular health.